[
    "{\"step_by_step_thinking\": \"The patient is a 65-year-old woman who is postmenopausal and has a family history of breast cancer. She is being considered for treatment with raloxifene, which is a selective estrogen receptor modulator (SERM). Raloxifene is commonly used for the prevention and treatment of osteoporosis. However, it is important to note that raloxifene has been associated with an increased risk of developing certain conditions. One of these conditions is pulmonary embolism, which is a known side effect of raloxifene. Cellulitis, breast cancer, and hypercholesterolemia are not known to be associated with raloxifene use.\", \"answer_choice\": \"A\"}"
]